Biohaven Ltd. (BHVN) Q4 2021 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biohaven Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:03.762 Good morning and welcome to the Biohaven Pharmaceuticals fourth quarter and full year 00:00:03.762 -- 00:00:09.416 2021 earnings call. At this time, all participants are in listen-only mode. 00:00:09.416 -- 00:00:13.418 After the speaker's presentation, there will be a question and answer session. 00:00:13.418 -- 00:00:17.221 If anyone should require operator assistance, please press star zero on your telephone 00:00:17.221 -- 00:00:21.584 keypad. Please be advised that today's conference will be recorded. 00:00:21.584 -- 00:00:25.527 I would now like to hand the conference over to Caroline Dirks from Biohaven. 00:00:25.527 -- 00:00:28.748 Thank you, Caroline. Please go ahead. 00:00:28.800 -- 00:00:35.322 Thank you, and welcome to the BioHaven fourth quarter and full year 2021 earnings call. 00:00:35.322 -- 00:00:40.403 Speaking on today's call are Dr. Vlad Chorich, our Chief Executive Officer, Matthew 00:00:40.403 -- 00:00:45.645 Butin, Chief Financial Officer, BJ Jones, Chief Commercial Officer, and Dr. 00:00:45.645 -- 00:00:50.486 Elise Stock, Chief Medical Officer. Also speaking on today's call are Dr. 00:00:50.486 -- 00:00:55.783 Michael Bozic and Dr. Stephen Dworski, who will be joining BioHaven as President, 00:00:55.783 -- 00:01:00.865 Biohaven Labs, and Senior Vice President, Biohaven Labs, respectively, and Cliff Bechtold, 00:01:00.865 -- 00:01:04.426 President and General Manager, Biohaven Ireland. 00:01:04.426 -- 00:01:09.287 We are also pleased to announce the addition of Jennifer Porcelli to Biohaven Pharmaceuticals 00:01:09.287 -- 00:01:12.108 as Vice President, Investor Relations. 00:01:12.108 -- 00:01:17.149 Earlier this morning, we issued a press release announcing the fourth quarter 2021 00:01:17.149 -- 00:01:20....